James E. Dahlman

12.8k total citations · 7 hit papers
76 papers, 7.3k citations indexed

About

James E. Dahlman is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, James E. Dahlman has authored 76 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in James E. Dahlman's work include RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (25 papers) and CRISPR and Genetic Engineering (12 papers). James E. Dahlman is often cited by papers focused on RNA Interference and Gene Delivery (51 papers), Advanced biosensing and bioanalysis techniques (25 papers) and CRISPR and Genetic Engineering (12 papers). James E. Dahlman collaborates with scholars based in United States, Netherlands and United Kingdom. James E. Dahlman's co-authors include Róbert Langer, Kalina Paunovska, David Loughrey, Mark W. Tibbitt, Daniel G. Anderson, Melissa P. Lokugamage, Cory D. Sago, Tyler Jacks, Avi Schroeder and Monte M. Winslow and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

James E. Dahlman

74 papers receiving 7.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treating metastatic cancer with nanotechnology

2011 952 citations James E. Dahlman, Róbert Langer et al. profile →
Drug delivery systems for RNA therapeutics

2022 867 citations Kalina Paunovska, David Loughrey et al. profile →
Emerging Frontiers in Drug Delivery

2016 781 citations James E. Dahlman, Róbert Langer et al. Journal of the American Chemical Society profile →
Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs

2021 357 citations Melissa P. Lokugamage, Daryll Vanover et al. Nature Biomedical Engineering profile →
Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure

2016 328 citations James E. Dahlman, Daniel G. Anderson et al. profile →
Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo

2022 130 citations Huanzhen Ni, Marine Z. C. Hatit et al. Nature Communications profile →
Drug delivery systems for CRISPR-based genome editors

2023 98 citations James E. Dahlman et al. profile →

Peers

Countries citing papers authored by James E. Dahlman

Since Specialization

Citations

This map shows the geographic impact of James E. Dahlman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Dahlman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Dahlman more than expected).

Fields of papers citing papers by James E. Dahlman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Dahlman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Dahlman. The network helps show where James E. Dahlman may publish in the future.

Co-authorship network of co-authors of James E. Dahlman

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Dahlman. A scholar is included among the top collaborators of James E. Dahlman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Dahlman. James E. Dahlman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing 2025 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), (unknown), (unknown), (unknown), James E. Dahlman, Mark R. Prausnitz	1
2	Amelioration of a von Willebrand disease type 2B phenotype in vivo upon treatment with allele-selective siRNAs 2025 ·Blood Advances ·(unknown), (unknown), Richard Dirven, (unknown), Ruben Bierings, Caterina Casari, Robert A. Cordfunke, James E. Dahlman, (unknown), Jan W. Drijfhout, Frank W.G. Leebeek, L. Renee Ruhaak, Elisa Schrader Echeverri, Jan Voorberg, Bart J.M. van Vlijmen, Cécile V. Denis, Jeroen Eikenboom	6
3	Light-field flow cytometry for high-resolution, volumetric and multiparametric 3D single-cell analysis 2024 ·Nature Communications ·Xuanwen Hua, (unknown), Biagio Mandracchia, (unknown), Wenhao Liu, Hyejin Kim, (unknown), (unknown), Kaitao Li, (unknown), (unknown), (unknown), Gabriel A. Kwong, Cheng Zhu, James E. Dahlman, Shu Jia	22
4	High-throughput screens identify a lipid nanoparticle that preferentially delivers mRNA to human tumors in vivo 2023 ·Journal of Controlled Release ·Sebastian G. Huayamares, Melissa P. Lokugamage, (unknown), Alejandro J. Da Silva Sanchez, Hyejin Kim, (unknown), David Loughrey, (unknown), Yuning Hou, Bhagelu R. Achyut, Annette Ehrhardt, Jeong S. Hong, Cory D. Sago, Kalina Paunovska, Elisa Schrader Echeverri, Daryll Vanover, Philip J. Santangelo, Eric J. Sorscher, James E. Dahlman	45
5	Multivalent Targeting of the Asialoglycoprotein Receptor by Virus‐Like Particles 2023 ·Small ·Robert Hincapie, (unknown), Michael M. Baksh, Carlos Sanhueza, Elisa Schrader Echeverri, Hyejin Kim, Kalina Paunovska, (unknown), Minghao Xu, James E. Dahlman, M. G. Finn	8
6	Nanoparticle stereochemistry-dependent endocytic processing improves in vivo mRNA delivery 2023 ·Nature Chemistry ·Marine Z. C. Hatit, Curtis Dobrowolski, Melissa P. Lokugamage, David Loughrey, Huanzhen Ni, Chiara Zurla, Alejandro J. Da Silva Sanchez, (unknown), Sebastian G. Huayamares, Ryan Zenhausern, Kalina Paunovska, Hannah E. Peck, Jinhwan Kim, Manaka Sato, Jacob I. Feldman, (unknown), Ana Cristian, YongTae Kim, Philip J. Santangelo, James E. Dahlman	49
7	The Transcriptional Response to Lung-Targeting Lipid Nanoparticles in Vivo 2023 ·Nano Letters ·(unknown), Melissa P. Lokugamage, Hyejin Kim, Curtis Dobrowolski, Ryan Zenhausern, David Loughrey, Sebastian G. Huayamares, Marine Z. C. Hatit, Huanzhen Ni, (unknown), Alejandro J. Da Silva Sanchez, Kalina Paunovska, Elisa Schrader Echeverri, Aram Shajii, Hannah E. Peck, Philip J. Santangelo, James E. Dahlman	46
8	Augmented lipid-nanoparticle-mediated in vivo genome editing in the lungs and spleen by disrupting Cas9 activity in the liver 2022 ·Nature Biomedical Engineering ·Cory D. Sago, Melissa P. Lokugamage, David Loughrey, Kevin E. Lindsay, Robert Hincapie, (unknown), Sujay Kalathoor, Manaka Sato, Elisa Schrader Echeverri, (unknown), Zubao Gan, Lena Gamboa, Kalina Paunovska, Carlos Sanhueza, Marine Z. C. Hatit, M. G. Finn, Philip J. Santangelo, James E. Dahlman	52
9	Piperazine-derived lipid nanoparticles deliver mRNA to immune cells in vivo breakdown → 2022 ·Nature Communications ·Huanzhen Ni, Marine Z. C. Hatit, Kun Zhao, David Loughrey, Melissa P. Lokugamage, Hannah E. Peck, (unknown), (unknown), YongTae Kim, Philip J. Santangelo, James E. Dahlman	130
10	Non-liver mRNA Delivery 2021 ·Accounts of Chemical Research ·David Loughrey, James E. Dahlman	132
11	Optimization of lipid nanoparticles for the delivery of nebulized therapeutic mRNA to the lungs breakdown → 2021 ·Nature Biomedical Engineering ·Melissa P. Lokugamage, Daryll Vanover, Jared Beyersdorf, Marine Z. C. Hatit, (unknown), Elisa Schrader Echeverri, Hannah E. Peck, Huanzhen Ni, Jeong‐Kee Yoon, YongTae Kim, Philip J. Santangelo, James E. Dahlman	357
12	Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands 2020 ·Bioengineering & Translational Medicine ·Zubao Gan, Melissa P. Lokugamage, Marine Z. C. Hatit, David Loughrey, Kalina Paunovska, Manaka Sato, Ana Cristian, James E. Dahlman	59
13	Constrained Nanoparticles Deliver siRNA and sgRNA to T Cells In Vivo without Targeting Ligands 2019 ·Advanced Materials ·Melissa P. Lokugamage, Cory D. Sago, Zubao Gan, (unknown), James E. Dahlman	126
14	Cell Subtypes Within the Liver Microenvironment Differentially Interact with Lipid Nanoparticles 2019 ·Cellular and Molecular Bioengineering ·Cory D. Sago, (unknown), Melissa P. Lokugamage, Zubao Gan, James E. Dahlman	39
15	Using Large Datasets to Understand Nanotechnology 2019 ·Advanced Materials ·Kalina Paunovska, David Loughrey, Cory D. Sago, Róbert Langer, James E. Dahlman	47
16	Nanoparticles That Deliver RNA to Bone Marrow Identified by in Vivo Directed Evolution 2018 ·Journal of the American Chemical Society ·Cory D. Sago, Melissa P. Lokugamage, Fatima Z. Islam, (unknown), Manaka Sato, James E. Dahlman	108
17	Modifying a Commonly Expressed Endocytic Receptor Retargets Nanoparticles in Vivo 2018 ·Nano Letters ·Cory D. Sago, Melissa P. Lokugamage, (unknown), (unknown), Nirav N. Shah, (unknown), Anton V. Bryksin, James E. Dahlman	42
18	Barcoding chemical modifications into nucleic acids improves drug stability in vivo 2018 ·Journal of Materials Chemistry B ·Cory D. Sago, Sujay Kalathoor, (unknown), (unknown), (unknown), Anton V. Bryksin, James E. Dahlman	18
19	A Direct Comparison of in Vitro and in Vivo Nucleic Acid Delivery Mediated by Hundreds of Nanoparticles Reveals a Weak Correlation 2018 ·Nano Letters ·Kalina Paunovska, Cory D. Sago, Christopher M. Monaco, William Henry Hudson, Lena Gamboa, (unknown), Sujay Kalathoor, Daryll Vanover, Philip J. Santangelo, Rafi Ahmed, Anton V. Bryksin, James E. Dahlman	193
20	Nanotechnology for In vivo Targeted siRNA Delivery 2014 ·Advances in genetics ·James E. Dahlman, Kevin Kauffman, Róbert Langer, Daniel G. Anderson	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact